Home DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac
 

Keywords :   


DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac

2014-10-01 11:13:37| Biotech - Topix.net

DanDrit Biotech A/S , the subsidiary of DanDrit Biotech USA, Inc. , a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST - National Institute for Cancer Research known as the San Martino Hospital of Genoa. Dr. Alberto Sobrero, the Head of the Medical Oncology Unit at the San Martino Hospital is principal investigator of the randomized multicenter study.

Tags: agreement signs clinical trials

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »